Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 16
Item hits:
Issue DateTitleAuthor(s)
23-Oct-2017Thirty years of OncogeneMiller, G; Stebbing, J
12-Dec-2017Brief report: geographic variation in EGFR mutation frequency in lung adenocarcinoma may be explained by interethnic genetic variationSoraas, L; Stebbing, J; National Institute for Health Research; Action Against Cancer
22-Jun-2017MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (vol 9, e85935, 2014)Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N, et al
14-Feb-2017Lineage-specific genes are prominent DNA damage hotspots during leukemic transformation of B-cell precursorsBoulianne, B; Robinson, ME; May, PC; Castellano, L; Blighe, K, et al
1-Jul-2017CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialStebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al
1-Oct-2017MicroRNAs Associated with Small Bowel Neuroendocrine Tumours and Their MetastasesFrampton, AE; Miller, HC; Malczewska, A; Ottaviani, S; Stronach, EA, et al
16-Oct-2017The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses.Stebbing, J; Sanders, DA; National Institute for Health Research
29-Aug-2017Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsIzumchenko, E; Paz, K; Ciznadija, D; Sloma, I; Katz, A, et al
3-Aug-2017The tumor suppressor protein OPCML potentiates anti-EGFR and anti-HER2 targeted therapy in HER2-positive ovarian and breast cancer.Zanini, E; Louis, LS; Antony, J; Karali, E; Okon, IS, et al
26-Jul-2017Quackery Chilli-too hot to handle?Craddock, C; Cathcart, P; Stebbing, J